Folic acid blocks ferroptosis induced by cerebral ischemia and reperfusion through regulating Folate hydrolase transcriptional adaptive program.

adaptive transcription cerebral ischemia reperfusion ferroptosis folic acid glutamate carboxypeptidase Ⅱ

Journal

The Journal of nutritional biochemistry
ISSN: 1873-4847
Titre abrégé: J Nutr Biochem
Pays: United States
ID NLM: 9010081

Informations de publication

Date de publication:
16 Nov 2023
Historique:
received: 25 02 2023
revised: 17 10 2023
accepted: 08 11 2023
medline: 19 11 2023
pubmed: 19 11 2023
entrez: 18 11 2023
Statut: aheadofprint

Résumé

Cerebral ischemia-reperfusion (I/R) injury is notably linked with folic acid (FA) deficiency. The aim of our investigation was to explore the effects and underlying mechanisms by which FA mitigates I/R, specifically through regulating the GCPII transcriptional adaptive program. Initially, we discovered that following cerebral I/R, levels of FA, methionine synthase (MTR), and methylenetetrahydrofolate reductase (MTHFR) were decreased, while GCPII expression was elevated. Secondly, administering FA could mitigate cognitive impairment and neuronal damage induced by I/R. Thirdly, the mechanism of FA supplementation involved suppressing the transcriptional factor Sp1, subsequently inhibiting GCPII transcription, reducing Glu content, obstructing cellular ferroptosis, and alleviating cerebral I/R injury. In summary, our data demonstrate that FA affords protection against cerebral I/R injury by inhibiting the GCPII transcriptional adaptive response. These findings unveil that targeting GCPII might be a viable therapeutic strategy for cerebral I/R.

Identifiants

pubmed: 37979712
pii: S0955-2863(23)00261-9
doi: 10.1016/j.jnutbio.2023.109528
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

109528

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no conflicts of interest to disclose. All authors approved the final article.

Auteurs

Peng Wang (P)

Department of Physiology, Harbin Medical University-Daqing, Daqing, Heilongjiang 163319, China.

Yangyang Huang (Y)

Department of Pediatrics, Daqing People's Hospital, Daqing, Heilongjiang 163319, China.

Buxun Sun (B)

Department of Physiology, Harbin Medical University-Daqing, Daqing, Heilongjiang 163319, China.

Hongpeng Chen (H)

Department of Physiology, Harbin Medical University-Daqing, Daqing, Heilongjiang 163319, China.

YiFan Ma (Y)

Department of Physiology, Harbin Medical University-Daqing, Daqing, Heilongjiang 163319, China.

Yuhang Liu (Y)

Department of Physiology, Harbin Medical University-Daqing, Daqing, Heilongjiang 163319, China.

Tao Yang (T)

Department of Pharmacology, Harbin Medical University-Daqing, Daqing, Heilongjiang 163319, China.

Hongbo Jin (H)

Department of Physiology, Harbin Medical University, Harbin, Heilongjiang 150081, China. Electronic address: HongboJinHMU2000@163.com.

Yuandong Qiao (Y)

Department of Genetics, Harbin Medical University-Daqing, Daqing, Heilongjiang 163319, China. Electronic address: qiaoyuandong@hrbmu.edu.cn.

Yongggang Cao (Y)

Department of Pharmacology, Harbin Medical University-Daqing, Daqing, Heilongjiang 163319, China. Electronic address: yonggangcaodr2014@163.com.

Classifications MeSH